232 related articles for article (PubMed ID: 6505358)
21. Determination of the isoniazid acetylator phenotype in a West African population.
Salako LA; Aderounmu AF
Tubercle; 1977 Jun; 58(2):109-12. PubMed ID: 878015
[TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacokinetics of isoniazid.
Weber WW; Hein DW
Clin Pharmacokinet; 1979; 4(6):401-22. PubMed ID: 391461
[TBL] [Abstract][Full Text] [Related]
23. Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites.
Mitchell JR; Thorgeirsson UP; Black M; Timbrell JA; Snodgrass WR; Potter WZ; Jollow HR; Keiser HR
Clin Pharmacol Ther; 1975 Jul; 18(1):70-9. PubMed ID: 1149365
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic interaction of simultaneously administered isoniazid and phenytoin in patients with tuberculous meningitis or tuberculoma having seizures.
Adole PS; Singh A; Kharbanda PS; Sharma S
Eur J Pharmacol; 2013 Aug; 714(1-3):157-62. PubMed ID: 23792142
[TBL] [Abstract][Full Text] [Related]
25. Acetylation.
Weber WW
Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
[TBL] [Abstract][Full Text] [Related]
26. Clinical consequences of polymorphic acetylation of basic drugs.
Drayer DE; Reidenberg MM
Clin Pharmacol Ther; 1977 Sep; 22(3):251-8. PubMed ID: 19187
[TBL] [Abstract][Full Text] [Related]
27. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
[TBL] [Abstract][Full Text] [Related]
28. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
Bouayad Z; Chevalier B; Maurin R; Bartal M
Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595
[TBL] [Abstract][Full Text] [Related]
29. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
Augustynowicz-Kopeć E; Zwolska Z
Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
[TBL] [Abstract][Full Text] [Related]
30. [The importance of estimating the individual acetylation rate in modern tuberculosis treatment].
Duru S
Mikrobiyol Bul; 1979 Jan; 13(1):53-61. PubMed ID: 555792
[TBL] [Abstract][Full Text] [Related]
31. Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
Seth V; Seth SD; Beotra A; Singh U
Dev Pharmacol Ther; 1988; 11(1):32-6. PubMed ID: 3383719
[TBL] [Abstract][Full Text] [Related]
32. Effect of coadministration of procainamide and isoniazid on each other's acetylation pathway.
Schneck DW; Sprouse JS; Shiroff RA; Vary JE; DeWitt FO; Hayes AH
Pharmacology; 1979; 18(1):34-41. PubMed ID: 419159
[TBL] [Abstract][Full Text] [Related]
33. Anti tubercular treatment induced hepatotoxicity: does acetylator status matter?
Singh J; Garg PK; Thakur VS; Tandon RK
Indian J Physiol Pharmacol; 1995 Jan; 39(1):43-6. PubMed ID: 7705868
[TBL] [Abstract][Full Text] [Related]
34. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
Ellard GA
Cas Lek Cesk; 1984 Feb; 123(6):158-64. PubMed ID: 6697364
[No Abstract] [Full Text] [Related]
35. [Bioavailability of isoniazid in healthy volunteers--fast and slow INH acetylators].
Augustynowicz-Kopeć E; Zwolska Z; Niemirowska-Mikulska H
Pneumonol Alergol Pol; 2002; 70(3-4):167-79. PubMed ID: 12271964
[TBL] [Abstract][Full Text] [Related]
36. Hepatic function in relation to acetylator phenotype in children treated with antitubercular drugs.
Seth V; Beotra A
Indian J Med Res; 1989 Sep; 89():306-9. PubMed ID: 2628292
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.
Hall S
Acta Med Scand; 1981; 209(6):505-7. PubMed ID: 7257867
[TBL] [Abstract][Full Text] [Related]
38. [Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].
Powłowska I; Rakowska Z
Pneumonol Pol; 1978 Aug; 46(8):605-12. PubMed ID: 714703
[No Abstract] [Full Text] [Related]
39. Modulation of CYP2E1 activity by isoniazid in rapid and slow N-acetylators.
O'Shea D; Kim RB; Wilkinson GR
Br J Clin Pharmacol; 1997 Jan; 43(1):99-103. PubMed ID: 9056059
[TBL] [Abstract][Full Text] [Related]
40. Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.
Aït Moussa L; Khassouani CE; Hüe B; Jana M; Bégaud B; Soulaymani R
Int J Clin Pharmacol Ther; 2002 Dec; 40(12):548-53. PubMed ID: 12503812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
